Addition of enoximone to adrenergic agents in the management of severe heart failure
OBJECTIVETo assess the hemodynamic effects of the addition of small bolus doses of the phos-phodiesterase inhibitor enoximone to adrenergic therapy in patients with severe heart failure. DESIGNOpen label, prospective study. SETTINGMultidisciplinary department of intensive care in a university academ...
Gespeichert in:
Veröffentlicht in: | Critical care medicine 1992-08, Vol.20 (8), p.1102-1106 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVETo assess the hemodynamic effects of the addition of small bolus doses of the phos-phodiesterase inhibitor enoximone to adrenergic therapy in patients with severe heart failure.
DESIGNOpen label, prospective study.
SETTINGMultidisciplinary department of intensive care in a university academic hospital.
PATIENTSTwelve surgical patients after cardiac surgery and ten medical patients with ischemic or dilated cardiomyopathy who had signs of altered tissue perfusion associated with a low cardiac index ( |
---|---|
ISSN: | 0090-3493 1530-0293 |
DOI: | 10.1097/00003246-199208000-00006 |